PurposeThe last decade has seen a considerable rise in ventricular assist device (VAD) support as bridge to heart transplant (HT) coupled with increasing transplantation for single ventricle congenital heart disease (SV CHD). Neurologic events (NE) are common in both patient groups. We sought to describe NE before and after HT in the modern era among children and young adults.MethodsWe performed a single center retrospective review of patients who underwent HT between 1/2013 and 4/2020. NE included seizures, stroke, subdural hemorrhage (SDH) and posterior reversible encephalopathy syndrome (PRES). Clinical characteristics were compared between patients with and without post-HT NE.ResultsOverall 163 patients met study criteria, of whom 54 (33%) had a pre-HT NE and 29 (18%) had at least one post-HT NE. Post-HT NE included seizures in 23/163 (14%), strokes in 10/163 (6%), SDH in 9/163 (6%), and PRES in 7/163 (4%). Median time from HT to first post-HT NE was 24 days (IQR 3, 277). Post-HT NE were associated with SDH (6/29 (21%) vs 9/134 (7%), p=0.03), pre-HT ICU admission (11/29 (38%) vs 21/134 (16%), p=0.009), and allograft ischemic time (250 min (IQR 221, 224) vs 223 min (IQR 189, 250), p=0.001), and not with pre-HT NE, SV CHD, or VAD support. ICU admission was an independent predictor of post-HT NE on multivariate analysis (hazard ratio 2.87 (CI 1.09, 7.62), p=0.03). Post-HT NE were associated with significantly decreased survival.ConclusionPost-HT NE are common in children and young adults and occur early post-HT. They are associated with ICU status at time of HT, and not with SV CHD or pre-HT VAD support. Post-HT neurologic events portend a poor prognosis, with 50% mortality by 5 years. The last decade has seen a considerable rise in ventricular assist device (VAD) support as bridge to heart transplant (HT) coupled with increasing transplantation for single ventricle congenital heart disease (SV CHD). Neurologic events (NE) are common in both patient groups. We sought to describe NE before and after HT in the modern era among children and young adults. We performed a single center retrospective review of patients who underwent HT between 1/2013 and 4/2020. NE included seizures, stroke, subdural hemorrhage (SDH) and posterior reversible encephalopathy syndrome (PRES). Clinical characteristics were compared between patients with and without post-HT NE. Overall 163 patients met study criteria, of whom 54 (33%) had a pre-HT NE and 29 (18%) had at least one post-HT NE. Post-HT NE included seizures in 23/163 (14%), strokes in 10/163 (6%), SDH in 9/163 (6%), and PRES in 7/163 (4%). Median time from HT to first post-HT NE was 24 days (IQR 3, 277). Post-HT NE were associated with SDH (6/29 (21%) vs 9/134 (7%), p=0.03), pre-HT ICU admission (11/29 (38%) vs 21/134 (16%), p=0.009), and allograft ischemic time (250 min (IQR 221, 224) vs 223 min (IQR 189, 250), p=0.001), and not with pre-HT NE, SV CHD, or VAD support. ICU admission was an independent predictor of post-HT NE on multivariate analysis (hazard ratio 2.87 (CI 1.09, 7.62), p=0.03). Post-HT NE were associated with significantly decreased survival. Post-HT NE are common in children and young adults and occur early post-HT. They are associated with ICU status at time of HT, and not with SV CHD or pre-HT VAD support. Post-HT neurologic events portend a poor prognosis, with 50% mortality by 5 years.